These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4122297)

  • 21. The metabolic fate of the coronary dilator 4-(3,4,5,-trimethoxycinnamoyl)-1-(N-isopropylcarbamoylmethyl)-piperazine in the rat, dog and man.
    Chasseaud LF; Hawkins DR; Fry BJ; Lewis JD; Saggers VH; Sword IP
    Xenobiotica; 1974 Jul; 4(7):393-407. PubMed ID: 4432531
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THE FATE OF DICOUMAROL--14C IN THE RAT.
    CHRISTENSEN F
    Acta Pharmacol Toxicol (Copenh); 1965; 22():141-51. PubMed ID: 14284192
    [No Abstract]   [Full Text] [Related]  

  • 23. An experimental model in dogs for studying interactions of drugs with bishydroxycoumarin.
    Welch RM; Harrison YE; Conney AH; Burns JJ
    Clin Pharmacol Ther; 1969; 10(6):817-25. PubMed ID: 4186901
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of protein biosynthesis in mouse liver by salicylate.
    Dawkins PD; McArthur JN; Smith MJ
    Biochem Pharmacol; 1971 Jun; 20(6):1303-12. PubMed ID: 5118125
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibitory effect of salicylate on the incorporation of L-(U-14C)leucine into the protein of rat tissue preparations in vitro.
    Dawkins PD; Gould BJ; Smith MJ
    Biochem J; 1966 Jun; 99(3):703-7. PubMed ID: 5964967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the biliary excretion of 14C-dicumarol in the rat.
    Husain S; Eisenbrandt LL; Wosilait WD
    Drug Metab Dispos; 1973; 1(2):523-9. PubMed ID: 4132217
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative pharmacokinetics of coumarin anticoagulants XXXI: Effect of plasma protein binding on distribution kinetics of dicumarol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharm Sci; 1977 Dec; 66(12):1741-3. PubMed ID: 72819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of dicumarol metabolites in bile of rats.
    Conway WD; Lee FH; Neufeld L
    J Pharm Sci; 1975 Jul; 64(7):1158-62. PubMed ID: 50434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of dicumarol-14 C by rat-liver microsomes.
    Lee FH; Conway WD
    Pharmacol Res Commun; 1976 Oct; 8(5):469-75. PubMed ID: 68481
    [No Abstract]   [Full Text] [Related]  

  • 30. The fate of atropine in the puppy.
    Windbladh B
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):46-64. PubMed ID: 4741039
    [No Abstract]   [Full Text] [Related]  

  • 31. The site of the inhibitory action of salicylate on protein biosynthesis in vitro.
    Burleigh M; Smith MJ
    J Pharm Pharmacol; 1971 Jul; 23(7):519-27. PubMed ID: 4397452
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats.
    Yesair DW; Remington L; Callahan M; Kensler CJ
    Biochem Pharmacol; 1970 May; 19(5):1591-600. PubMed ID: 5513943
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative pharmacokinetics of coumarin anticoagulants. XLII: Effect of phenobarbital on systemic availability of orally administered dicumarol in rats with ligated bile ducts.
    Crow JW; Gibaldi M; Levy G
    J Pharm Sci; 1979 Oct; 68(10):1309-12. PubMed ID: 92562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the metabolic fate of ( 14 C)-labelled ( )-2,3-dehydroemetine in the rat.
    Johnson RK; Jondorf WR
    Xenobiotica; 1973 Feb; 3(2):85-95. PubMed ID: 4716643
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between dicumarol distribution and the effect of enzyme induction on dicumarol elimination in rats.
    Lai CM; Yacobi A; Levy G
    J Pharmacol Exp Ther; 1976 Oct; 199(1):74-81. PubMed ID: 62050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver and fecal bishydroxycoumarin following repeated toxic oral bishydroxycoumarin administration in ground squirrels.
    Colvin HW; Skaife DD; Morrison JT
    Toxicol Appl Pharmacol; 1971 Jun; 19(2):155-63. PubMed ID: 4105823
    [No Abstract]   [Full Text] [Related]  

  • 37. Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration.
    Kozatani J; Okui M; Matsubara T; Nishida M
    J Antibiot (Tokyo); 1972 Feb; 25(2):86-93. PubMed ID: 5034810
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative pharmacokinetics of coumarin anticoagulants XXIV: Effect of treatment with phenobarbital on serum protein binding of warfarin and dicumarol in rats.
    Yacobi A; Slattery JT; Levy G
    J Pharm Sci; 1977 Jul; 66(7):941-3. PubMed ID: 69705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lowering of plasma concentrations of (+)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid (naproxen) by aspirin in rats.
    Chaplin MD
    Biochem Pharmacol; 1973 Jul; 22(13):1589-98. PubMed ID: 4729806
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative pharmacokinetics of coumarin anticoagulants. II. Pharmacokinetics of bishydroxycoumarin elimination in the rat, guinea pig, dog, and rhesus monkey.
    Nagashima R; Levy G; Back N
    J Pharm Sci; 1968 Jan; 57(1):68-71. PubMed ID: 4172324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.